Intellia Therapeutics Inc (NTLA) short volume · rev $67.7M
Intellia Therapeutics Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 523,120 | 1,114,783 | 46.9% |
| 2026-10-20 | 443,917 | 1,106,820 | 40.1% |
| 2026-10-19 | 618,071 | 1,142,622 | 54.1% |
| 2026-10-16 | 1,063,855 | 2,570,235 | 41.4% |
| 2026-10-15 | 894,442 | 1,832,723 | 48.8% |
| 2026-10-14 | 1,254,645 | 2,397,043 | 52.3% |
| 2026-10-13 | 1,024,876 | 2,042,931 | 50.2% |
| 2026-10-12 | 771,588 | 1,601,359 | 48.2% |
| 2026-10-09 | 1,583,263 | 2,842,466 | 55.7% |
| 2026-10-08 | 1,671,731 | 3,136,634 | 53.3% |
NTLA short volume FAQ
What was NTLA's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Intellia Therapeutics Inc (NTLA) was 523,120 shares, 46.9% of 1,114,783 total volume.
How many NTLA short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Intellia Therapeutics Inc (NTLA), from Oct 8, 2026 through Oct 21, 2026.
How did NTLA short volume percent change from the prior cached session?
Cached FINRA short volume for Intellia Therapeutics Inc (NTLA) moved from 40.1% on Oct 20, 2026 to 46.9% on Oct 21, 2026, up 6.8 percentage points.
What was the highest NTLA short volume percent on this page?
The highest cached FINRA short volume on this page is 55.7% of total volume on Oct 9, 2026.
What is NTLA's latest revenue?
Latest cached Intellia Therapeutics Inc (NTLA) revenue for Dec 31, 2025 was $67.7M. Statements: https://lician.com/financials/ntla
What is the average NTLA short volume percent on this page?
Across 10 cached sessions on this page, Intellia Therapeutics Inc (NTLA) short volume averaged 49.1% of total volume.
Where is NTLA short volume listed?
Cached FINRA short volume for Intellia Therapeutics Inc (NTLA) is listed at https://lician.com/short-interest/ntla.
Not investment advice. Cached rows, not a live tape.